You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Sale Disclosure
Bernstein Harold · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$434.74K
Bernstein Harold President, R&d & CMO
MAZE
Maze Therapeutics
MAZE
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
MAZE daily price context
Close on/before transaction
$26.65
Oct 1, 2026
First close after public filing
$26.43
Oct 5, 2026
30-day return after filing
+14.91%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 16,141 shares @ $26.93
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002050172-26-000038
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$602.93K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE | Exercise | Oct 1, 2026 | $168.19K |
| Maze Therapeutics, Inc. MAZE Current | Sale | Oct 1, 2026 | $434.74K |
| Maze Therapeutics, Inc. MAZE | Exercise | Oct 1, 2026 | $0 |